{"DataElement":{"publicId":"2515890","version":"1","preferredName":"Molecular Sequence Analysis Genetic Marker Assessment Specify","preferredDefinition":"a text field to describe DNA molecules examined by computational analysis to identify alterations that may indicate risk for developing disease due to changes in gene expression or regulation.","longName":"MO_SEQAN_GNMA_ASS_SP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2010547","version":"3","preferredName":"Molecular Sequence Analysis Genetic Marker Assessment","preferredDefinition":"related to examination by computational analysis of DNA molecules to identify alterations that may indicate risk for developing disease due to changed elements in the regulation of gene expression.","longName":"MOL_SEQAN_GENMAR_ASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2497248","version":"1","preferredName":"Molecular Sequence Analysis","preferredDefinition":"Molecular; relating to or produced by or consisting of molecules.:1) Determination of the sequence of component residues in a macromolecule, e.g. amino acids in a protein or nucleotide bases in DNA/RNA.  2) Computational analysis performed to determine the similarities between nonidentical proteins or molecules of DNA or RNA.  In the case of proteins this helps identify regions involved in specific common functions (e.g. catalysis, ligand binding) or processed in a similar fashion (e.g. glycosylation, nuclear transport).  In the case of DNA/RNA, sequence analysis aids in the identification of cis-acting elements active in the regulation of gene expression or other genetic activities, or processing of RNA transcription products.","longName":"C25574:C17565","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular","conceptCode":"C25574","definition":"Relating to or produced by or consisting of molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sequence Analysis","conceptCode":"C17565","definition":"The determination of the sequence of component residues in a macromolecule, e.g. amino acids in a protein or nucleotide bases in DNA/RNA or the computational analysis performed to determine the similarities between nonidentical proteins or molecules of DNA or RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"18F641F3-345A-6FBD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-19","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-19","modifiedBy":"ONEDATA","dateModified":"2006-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497250","version":"1","preferredName":"Genetic Marker Assessment","preferredDefinition":"Alterations in DNA that may indicate an increased risk of developing a specific disease or disorder.:Examination of the body by auscultation, palpation, percussion, inspection, and olfaction.  (Taber's)","longName":"C16622:C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Marker","conceptCode":"C16622","definition":"A segment of DNA with an identifiable physical location on a chromosome and whose inheritance can be followed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"18F641F3-346C-6FBD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-19","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-19","modifiedBy":"ONEDATA","dateModified":"2006-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"18F380C7-CD72-1B1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-19","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018806","version":"1","preferredName":"Assessment Specify","preferredDefinition":"The free text field to specify the assessment performed.","longName":"ASSESS_SPEC","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B9698B67-5B33-24B9-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-14","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-21","modifiedBy":"KNABLEJ","dateModified":"2017-08-23","changeDescription":"8/23/17 jk added registration status and CSI per Round 5 finalization task; capitalized first word in definition. --- released","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811958","version":"1","longName":"Molecular Analysis","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811935","version":"1","longName":"Pathology Leukemia","context":"CTEP"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Other specify","url":null,"context":"CTEP"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Molecular Marker","url":null,"context":"Theradex"},{"name":"CRF Text1","type":"Alternate Question Text","description":"List gene assessed","url":null,"context":"Alliance"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Specify gene name","url":null,"context":"Alliance"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BB31CC9-4FB3-4A9D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-08-23","modifiedBy":"MORENOC","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}